BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9816247)

  • 21. Placental site trophoblastic tumour: clinical features and management.
    Hassadia A; Gillespie A; Tidy J; Everard R G N J; Wells M; Coleman R; Hancock B
    Gynecol Oncol; 2005 Dec; 99(3):603-7. PubMed ID: 16085293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic origin of malignant trophoblastic neoplasms analyzed by sequence tag site polymorphic markers.
    Shahib N; Martaadisoebrata D; Kondo H; Zhou Y; Shinkai N; Nishimura C; Kiyoko K; Matsuda T; Wake N; Kato HD
    Gynecol Oncol; 2001 May; 81(2):247-53. PubMed ID: 11330958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and pathologic characteristics and prognosis of placental site trophoblastic tumor.
    Zhao J; Xiang Y; Wan XR; Cui QC; Yang XY
    J Reprod Med; 2006 Dec; 51(12):939-44. PubMed ID: 17253041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Factors influencing the results of treating trophoblastic tumor patients].
    Semenovskiĭ AV
    Vopr Onkol; 1978; 24(3):39-44. PubMed ID: 206019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of malignant trophoblastic tumors.
    Wang SL; Zhang CS; Peng HQ; Wu KH
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1553-60. PubMed ID: 2543311
    [No Abstract]   [Full Text] [Related]  

  • 26. Gestational trophoblastic disease. The effect of duration of disease and hCG titer on response to therapy.
    Lurain JR; Brewer JI; Torok EE; Halpern B
    J Reprod Med; 1982 Jul; 27(7):401-5. PubMed ID: 6288936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current approaches to diagnosis and treatment of gestational trophoblastic disease.
    Smith DB; O'Reilly SM; Newlands ES
    Curr Opin Obstet Gynecol; 1993 Feb; 5(1):84-91. PubMed ID: 8381037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen.
    Kim SJ; Bae SN; Kim JH; Kim CJ; Jung JK
    Gynecol Oncol; 1998 Nov; 71(2):247-53. PubMed ID: 9826467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Placental site trophoblastic tumor].
    Piura B; Shaco-Levy R
    Harefuah; 2007 Jan; 146(1):62-7, 77. PubMed ID: 17294852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gestational trophoblastic tumors: refining histologic diagnoses by using DNA flow and image cytometry.
    Lage JM
    Curr Opin Obstet Gynecol; 1994 Aug; 6(4):359-63. PubMed ID: 7742500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Assessment of staging and prognostic scoring system for malignant trophoblastic neoplasia].
    Wang YX; Zhang X; Guan YL; Jang AY; Long ZQ
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):87-90. PubMed ID: 15840285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factors affecting late treatment results with uterine choriocarcinoma patients].
    Mokshin VE
    Vopr Onkol; 1985; 31(7):62-8. PubMed ID: 4024562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gestational trophoblastic tumors].
    Droz JP; Lhommé C
    Rev Prat; 1992 Apr; 42(7):817-22. PubMed ID: 1318577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of trophoblastic neoplasia at the Cancer Control Agency of British Columbia.
    Boyes DA; Pankratz E; Galliford B; White GM; Fairey RN; Yuen BH
    Can Med Assoc J; 1977 Oct; 117(7):753-6. PubMed ID: 198082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases.
    Chang YL; Chang TC; Hsueh S; Huang KG; Wang PN; Liu HP; Soong YK
    Gynecol Oncol; 1999 May; 73(2):216-22. PubMed ID: 10329037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical characteristics and management of gestational trophoblastic disease in women aged 50 years or more].
    Feng FZ; Xiang Y; Wan XR; Yin SJ; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):605-8. PubMed ID: 16202316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of low risk of persistent trophoblastic disease in molar pregnancies.
    Niemann I; Petersen LK; Hansen ES; Sunde L
    Obstet Gynecol; 2006 May; 107(5):1006-11. PubMed ID: 16648403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours.
    Froeling FEM; Ramaswami R; Papanastasopoulos P; Kaur B; Sebire NJ; Short D; Fisher RA; Sarwar N; Wells M; Singh K; Ellis L; Horsman JM; Winter MC; Tidy J; Hancock BW; Seckl MJ
    Br J Cancer; 2019 Mar; 120(6):587-594. PubMed ID: 30792530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.